Juno Therapeutics

- NASDAQ:JUNO
  • Juno Therapeutics | Breakthrough Immunotherapies For Cancer
  • Locations

    • Seattle WA
  • Total Funding (USD)

    310.0 million
  • Industries

    Cyber Security
  • Security

    Type: ORD
    CUSIP: 48205A109
    ISIN: US48205A1097
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.